Christian H. Geisler

Author

Also Known As

C Geisler, C. Geisler, C. H. Geisler, C.H. Geisler, Christian Geisler, Christian H Geisler, Christian H. Geisler, Christian Hartmann Geisler, Geisler, C.

106

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Rigshospitalet Uppsala University Karolinska Institutet Lund University Amsterdam UMC Location University of Amsterdam

About

Christian H. Geisler is an author at Rigshospitalet specializing in oncology, hematology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	16	1.2K
2	Health Sciences	7	7	250
3	Cell Biology	2	2	60
4	Epidemiology	1	1	13
5	Geriatrics	1	1	13

Christian H. Geisler

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies Andreas Agathangelidis, Nikos Darzentas, Anastasia Hadzidimitriou, Blood	2012	382
Ibrutinib for previously untreated and relapsed or refractory chronic lymphocytic leukaemia with TP53 aberrations: a phase 2, single-arm trial Mohammed Farooqui, Janet Valdez, Sabrina Martyr, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaTp53 AberrationsSingle-arm TrialMedicine	2014	365
Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study Inhye E. Ahn, Mohammed Farooqui, Xin Tian, Blood	2018	197
Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study Franco Pandolfi, Thomas P. Loughran, Gordon Starkebaum, Cancer	1990	164
SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma – a Nordic Lymphoma Group study Lena Nordström, Sandra Sernbo, Patrik Edén, British Journal of Haematology ImmunologyTreated CohortPathologyPrognostic InformationTumor Biology	2014	127
In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: A cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients Christian H. Geisler, Preben Philip, B. Egelund Christensen, Leukemia Research Hematological MalignancyLymphoid NeoplasiaImmunophenotypic StudyMedicineMixed-phenotype Acute Leukemia	1997	113
Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study Marinus H. J. van Oers, Kazimierz Kuliczkowski, Lukáš Smolej, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaAutoimmune DiseaseMedicineHematology	2015	112
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study Panagiotis Baliakas, Anastasia Hadzidimitriou, Lesley-Ann Sutton, The Lancet Haematology Hematological MalignancyLymphoid NeoplasiaChronic Lymphocytic LeukaemiaMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2014	111
Distinct patterns of novel gene mutations in poor-prognostic stereotyped subsets of chronic lymphocytic leukemia: the case of SF3B1 and subset #2 Jonathan C. Strefford, L-A Sutton, Panagiotis Baliakas, Leukemia Hematological MalignancyPoor-prognostic Stereotyped SubsetsDistinct PatternsMedicineGenetics	2013	101
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia Rebeqa Gunnarsson, Larry Mansouri, Anders Isaksson, Haematologica	2011	100

Page 1